If you are old enough, you might recall a controversy in the early 1970s regarding the compound Laetrile, purported to prevent the spread of cancer. New York’s Memorial Sloan Kettering Cancer Center was ground zero in that firestorm.

In the early 1970s, America’s war on cancer was in full force, and Sloan Kettering was regarded as one of the world’s leading cancer research centers.

But Sloan Kettering’s Board of Directors swept positive findings about Laetrile under the rug when it became unprofitable and publicly unpopular for them to support it.

via Truth About a 40-Year Long Cover-Up of Laetrile Cancer Treatment.